CivaTech Oncology Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.86M
- Investors
-
2
CivaTech Oncology General Information
Description
Developer of polymer-based devices designed to bring improvements to low-dose-rate brachytherapy. The company's devices are fabricated for specific types of tumors and are used for the treatment of early-stage cancers, enabling healthcare professionals to substantially reduce procedure time, provide homogeneous dose distribution, and minimize trauma.
Contact Information
Website
www.civatechoncology.comCorporate Office
- Research Triangle Park
- Durham, NC 27709
- United States
Corporate Office
- Research Triangle Park
- Durham, NC 27709
- United States
CivaTech Oncology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 23. Grant | 01-Jan-2023 | $1.86M | Completed | Generating Revenue | ||
| 22. Later Stage VC (Series F) | 19-Nov-2021 | Completed | Generating Revenue | |||
| 21. Grant | 16-Apr-2021 | Completed | Generating Revenue | |||
| 20. Secondary Transaction - Private | 01-Apr-2021 | Completed | Generating Revenue | |||
| 19. Debt - PPP | 10-Apr-2020 | Completed | Generating Revenue | |||
| 18. Grant | 01-Jan-2018 | Completed | Generating Revenue | |||
| 17. Later Stage VC | 20-Dec-2017 | Completed | Generating Revenue | |||
| 16. Grant | 13-Sep-2017 | Completed | Generating Revenue | |||
| 15. Debt - General | 24-Feb-2017 | $5.93M | Completed | Generating Revenue | ||
| 14. Later Stage VC | 16-Dec-2016 | $2.71M | $5.93M | Completed | Generating Revenue |
CivaTech Oncology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series F | ||||||||
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 2,000,000 | $1.25 | $1.25 | 1x | $1.25 | 10.97% | ||
| Series A | 805,000 | $1 | $1 | 1x | $1 | 4.42% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
CivaTech Oncology Comparisons
Industry
Financing
Details
CivaTech Oncology Competitors (17)
One of CivaTech Oncology’s 17 competitors is Best Theratronics, a Corporate Backed or Acquired company based in Ottawa, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Best Theratronics | Corporate Backed or Acquired | Ottawa, Canada | ||||
| ViewRay | Formerly VC-backed | Bedford, OH | ||||
| Accuray | Formerly VC-backed | Madison, WI | ||||
| ProNova Solutions | Venture Capital-Backed | Maryville, TN | ||||
| Sensus Healthcare | Formerly VC-backed | Boca Raton, FL |
CivaTech Oncology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
CivaTech Oncology Patents
CivaTech Oncology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2882862-A1 | Brachytherapy devices and related methods having microencapsulated brachytherapy materials | Active | 25-Aug-2011 | ||
| CA-2882862-C | Brachytherapy devices and related methods having microencapsulated brachytherapy materials | Active | 25-Aug-2011 | ||
| EP-2747839-A1 | Brachytherapy devices and related methods having microencapsulated brachytherapy materials | Inactive | 25-Aug-2011 | ||
| EP-2747839-A4 | Brachytherapy devices and related methods having microencapsulated brachytherapy materials | Inactive | 25-Aug-2011 | ||
| US-10646724-B2 | Brachytherapy devices and related methods having microencapsulated brachytherapy materials | Active | 25-Aug-2011 | A61N5/1001 |
CivaTech Oncology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
CivaTech Oncology Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Cancer Institute | Government | |||
| U.S. Department of Health and Human Services | Government |
CivaTech Oncology FAQs
-
When was CivaTech Oncology founded?
CivaTech Oncology was founded in 2006.
-
Where is CivaTech Oncology headquartered?
CivaTech Oncology is headquartered in Durham, NC.
-
What is the size of CivaTech Oncology?
CivaTech Oncology has 6 total employees.
-
What industry is CivaTech Oncology in?
CivaTech Oncology’s primary industry is Therapeutic Devices.
-
Is CivaTech Oncology a private or public company?
CivaTech Oncology is a Private company.
-
What is CivaTech Oncology’s current revenue?
The current revenue for CivaTech Oncology is .
-
How much funding has CivaTech Oncology raised over time?
CivaTech Oncology has raised $13.9M.
-
Who are CivaTech Oncology’s investors?
National Cancer Institute and U.S. Department of Health and Human Services have invested in CivaTech Oncology.
-
Who are CivaTech Oncology’s competitors?
Best Theratronics, ViewRay, Accuray, ProNova Solutions, and Sensus Healthcare are some of the 17 competitors of CivaTech Oncology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
